<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863072</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1651</article-id><article-id pub-id-type="other">O0031</article-id><article-id pub-id-type="pii">S0924933824016511</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Investigation of peripheral inflammatory biomarkers in association with suicide risk in major depression</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Petho</surname><given-names>B.</given-names></name><xref rid="aff3755" ref-type="aff">
<sup>1</sup>
</xref><xref rid="cor1583" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Tenyi</surname><given-names>T.</given-names></name><xref rid="aff3755" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Herold</surname><given-names>R.</given-names></name><xref rid="aff3755" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Osvath</surname><given-names>P.</given-names></name><xref rid="aff3755" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Voros</surname><given-names>V.</given-names></name><xref rid="aff3755" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Simon</surname><given-names>D.</given-names></name><xref rid="aff3756" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Molnar</surname><given-names>C.</given-names></name><xref rid="aff3755" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kovacs</surname><given-names>M. A.</given-names></name><xref rid="aff3755" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="aff3755"><sup>1</sup>Department of Psychiatry and Psychotherapy</aff><aff id="aff3756"><sup>2</sup>Department of Immunology and Biotechnology, <institution>University of Pecs</institution>, Clinical Centre, <city>Pecs</city>, <country>Hungary</country></aff><author-notes><corresp id="cor1583"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1626">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S792</fpage><lpage>S793</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824016511a.pdf"/><abstract><sec id="sec9515"><title>Introduction</title><p>Suicide is the most severe consequence of major depressive disorder (MDD). The most novel researches assume the role of immunological dysregulation in the background &#x02013; several studies have reported alterations of inflammatory cells related to both MDD and suicidal behaviour (SB).</p></sec><sec id="sec9516"><title>Objectives</title><p>Changes in the number of certain immune cells and their ratios have been proposed as potential biomarkers of suicide risk (SR). The aim of our research was to investigate alterations of these values related not only to MDD as an assumed inflammatory state, but also to an increased risk of SB.</p></sec><sec id="sec9517"><title>Methods</title><p>
In our restrospective cohort study carried out between January 2015 and January 2020, we investigated laboratory parameters of psychiatric patients diagnosed with MDD (<italic toggle="yes">n</italic>=101). Individuals with recent (&#x02264;48 hours prior) suicide attempt (SA) (<italic toggle="yes">n</italic>=22) and with past SA (&#x0003e;48 hours prior) (<italic toggle="yes">n</italic>=19) represented the high SR group. MDD patients with no history of SA (<italic toggle="yes">n</italic>=60) composed the intermediate SR group. We compared the number of neutrophil granulocytes, monocytes, lymphocytes, platelets, leukocytes, neutrophil-to-lymphocyte (NLR), monocyte-to-lymphocyte (MLR), platelet-to-lymphocyte ratio (PLR), red blood cell distribution width (RDW) and erythrocyte sedimentation rate (ESR). Furthermore, we evaluated alterations of these parameters related to antidepressant (AD) treatment, which has been proved to have anti-inflammatory effects. Statistical analyses were carried out using GraphPad 9.5.0 and MedCalc 16.8 programmes.</p></sec><sec id="sec9518"><title>Results</title><p>
We found a significant increase in neutrophil granulocyte count (<italic toggle="yes">p</italic>=0.016), NLR (<italic toggle="yes">p</italic>=0.031, Fig. 1), monocyte count (<italic toggle="yes">p</italic>&#x02264;0.0001), MLR (<italic toggle="yes">p</italic>=0.005, Fig. 2), leukocyte count (<italic toggle="yes">p</italic>=0.048) and ESR (<italic toggle="yes">p</italic>=0.037) in patients with recent SA compared to patients with no history of SA. Moreover, there was a significant elevation in monocyte count (<italic toggle="yes">p</italic>&#x02264;0.0001), MLR (<italic toggle="yes">p</italic>=0.020, Fig. 3), ESR (<italic toggle="yes">p</italic>=0.041) and RDW (<italic toggle="yes">p</italic>=0.037) in patients with high SR compared to patients with intermediate SR. AD treatment resulted in a significant decrease in neutrophil granulocyte count (<italic toggle="yes">p</italic>=0.0163) and NLR (<italic toggle="yes">p</italic>=0.016), however, it did not affect the rest of the parameters.</p><p>
<bold>Image:</bold></p><p>
<fig position="float" id="fig0176"><graphic xlink:href="S0924933824016511-FIG0176" position="anchor"/></fig>
</p><p>
<bold>Image 2:</bold>
</p><p>
<fig position="float" id="fig0177"><graphic xlink:href="S0924933824016511-FIG0177" position="anchor"/></fig>
</p><p>
<bold>Image 3:</bold>
</p><p>
<fig position="float" id="fig0178"><graphic xlink:href="S0924933824016511-FIG0178" position="anchor"/></fig>
</p></sec><sec id="sec9519"><title>Conclusions</title><p>Assuming immunological mechanisms in the background of MDD and SB, our findings support the role of NLR as a biomarker of acute SR, though its alterations may be masked by AD therapy in the long term. However, MLR &#x02013; remaining unaffected by AD treatment &#x02013; may be a possible indicator of both acute and long term suicidal vulnerability. In order to further specify the diagnostic value of these parameters, future prospective research is needed.</p><p>The study was supported by the FIKP-IV and the TNIL projects.</p></sec><sec id="sec9520"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="2"/></counts></article-meta></front></article>